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Introduction
In this paper we present a summary of the 
development within "marine biotechnology" in 
Tromsoe/Norway, covering
a) Infrastructure in Tromsoe
b) R & D programmes (main areas)
c) R & D results
d) New commercial companies, and
e) Experience from development of these com­
panies.
In the city of Tromsoe, Norway, a network of 
academic research, higher education and commer­
cial activities within fisheries and aquaculture has 
been developed, creating a good environment for 
the development of new biotechnological in­
dustries.
Development Of Infrastructure 
In Tromsoe/Norway
As a result of overall planning at governmen­
tal levels in Norway during late 60’s and early 70’s, 
combining:
a) Norway’s strong position and interest in har­
vesting fish from the sea and improving our 
production of food products, and
b) politics for regional development,
the Norwegian government decided to establish the 
following new institutions:
The University of Tromsoe, with the 
Norwegian College of Fishery Science 
(NFH) (1972),
The Norwegian Fishery Research 
Council (NFFR) (head office in 
Trondheim), (1973),
Institute of Fishery Technology Re­
search (FTFI) (1974). Since 1991, it has 
become the Norwegian Institute of 
Fisheries and Aquaculture (Tromsoe).
Tromsoe is located far north in Norway, 
where fishing and, frequently aquaculture are the 
backbone activities of commercial life. Ap­
proximately two-thirds of the total catch in Norway 
is caught in the sea off the coast of northern Nor­
way. The city is a center of higher education and 
research; in relation to areas such as marine 
biotechnology and aquaculture it has the status of 
a national center. The Norwegian College of 
Fisheries Science under the University of Tromsoe, 
and the Norwegian Institute of Fisheries and 
Aquaculture are the two institutions in Tromsoe 
which are responsible for education, research and 
industrial innovations. The Institute has the 
primary purpose of transferring the results from 
basic and applied research into practical applica-
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tion and to formulate problems, tasks and challen­
ges which may influence the research priorities 
within the University. These two institutions have 
throughout the last 15 years worked closely 
together, both with regards to personnel and re­
search projects. This has been one very important 
factor for a successful transfer of research results 
into commercial products and processes.
The development in Tromsoe has been 
financed by R & D grants from the Research Coun­
cil, by funds directly from the Norwegian Ministry 
of Fisheries for investments in infrastructure (of­
fices, laboratories, etc) and by funds for regional 
development from other governmental ministries.
R & D Programmes
The social environment and affiliated com­
mercial activities of Tromsoe and northern Norway 
were (and are) strongly dominated by fisheries. 
Recently aquaculture is also playing an important 
role. The exposure of the R & D institutions and 
their researchers to the daily realities of these ac­
tivities, has influenced (and influences) strongly 
the choice of R & D. With the advantage of starting 
new activities in the mid 70’s from scratch, a con­
centration of R & D in a few selected areas was
easily accomplished, thereby making good use of 
limited funds.
Two initial areas of research with major im­
p lica tio n s  for acad em ic  resea rch  and 
establishment of commercial companies in the 
marine biotechnology sector of Tromsoe were:
utilization of fish processing waste, 
primarily fish viscera, and 
fish diseases and the microbiology of 
marine bacteria which are pathogenic to 
fish (Vibrio spp.).
The first project was a joint R & D project 
between NFH and FTFI, wherein the researchers at 
NFH concentrated on fundamental questions re­
lated to fish silage and its application, and in which 
FTFI developed processes for industrial produc­
tion and applications.
Scientists at NFH were also involved in 
R & D related to aquaculture, including disease 
prevention by vaccination and other aspects of fish 
health. Thus, with the development of aquaculture 
in Norway, an overall approach to R & D within 
marine biotechnology, combining activities/pos- 
sibilities in fisheries and aquaculture, was 
gradually developed (See Fig. 1).
Fig. 1. Schematic illustration of fish processing and utilization of by-products in fish 
processing and aquaculture.
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R & D Results And Commercial 
Applications
Some of the R & D results from the activities 
in Tromsoe will be described in the following with 
reference to application and commercial produc­
tion. More details of the commercial companies 
involved are given in a later chapter.
Biochemicals From Fish Waste
Utilization of fish processing waste; the 
silage technology
Fish processing waste, and in particular fish 
guts, was a pollution problem in Norway when 
NFH/FTFI started to look into the potential ap­
plications of this very interesting raw material, 
contain ing enzym es and other in teresting 
biomolecules. The first product to be developed 
was a deoiled fish silage which was used as feed 
for domestic animals, including farmed fish. For 
review see Raa and Gildberg (1982).
A silage of fish guts preserved by adding acid 
will be digested by enzymes present in the gut and 
thereby become liquid with a layer of oil on the 
surface. Studies of the biochemistry of this 
autolytic process (Raa and Gildberg, 1976) and of 
the enzymes involved (Gildberg, 1982) indicated 
new possible uses of fish viscera. A process for the 
industrial production of silage concentrate was 
developed (Raa, Gildberg and Str0m, 1983). Basic 
studies on the mode of attack by fish enzymes on 
various biological tissues of fish and other or­
ganisms gave rise to ideas for new applications of 
fish enzymes in the processing of food (Gildberg 
and Almas, 1983).
Liquid Fish Protein Concentrate
Based on the silage technology, A/S Rieber 
& Co produced a concentrate (45% dry weight) of 
the aqueous solution which results from autolysis 
of fish waste. This concentrate is used in extruded 
fish feeds and is added as a liquid prior to the 
extrusion process. The feed pellets which contain 
this concentrate have good functional properties
and there is less dust both in the production plant 
and in the final product. The concentrate has a 
protein value corresponding to the best quality 
LT-fish meal (low temperature dried) and ap­
parently also contributes to the a ttractan t 
properties of the feed. The production plant in 
Tromsoe has a capacity to produce 20,000 mt per 
year.
Proteases and peptone
Enzymes and peptone from fish viscera are 
produced by Marine Biochemicals A/S in a process 
which involves
acidification
autolysis by enzymes present in the fish 
guts, and
ultrafiltration and purification of the 
aqueous phase, yielding a mixture of 
enzymes (mainly pepsins) and an 
ultrafiltrate containing a mixture of 
amino acids and peptides.
Pepsins in the stomach of fish are stable in 
acid and can be filtered off after complete liquefac­
tion of an acid silage of fish viscera. The properties 
of pepsins from fish differ significantly from those 
of pepsins from warm-blooded animals; fish pep­
sins will therefore not necessarily compete with 
other pepsins on the market.
The ultrafiltrate, after removal of enzymes 
from acidified and autolysed fish viscera, is rich in 
amino acids, peptides and other extractives of fish. 
When the ultrafiltrate is neutralized, the clear liq­
uid is spray-dried to produce a peptone powder. 
This powder dissolves completely in water and 
forms a clear solution that is a better growth 
medium for certain bacteria than other commercial 
growth media (Clausen, Gildberg and Raa, 1985). 
This marine peptone particularly favours growth of 
marine bacteria and of lactic acid bacteria (Vecht- 
Lifskitz, Almas and Zomer, 1990). Therefore 
potential commercial applications are in the 
production of fish vaccines and of lactic acid bac­
teria used as starter cultures in preservation of
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grass silages, and eventually also of a fermented 
fish silage.
Nucleotides/nucleosides
In a joint venture with the fish processing 
industry in Norway, Marine Biochemicals A/S 
produces DNA from fish milt, and nucleosides 
from the same DNA by enzymatic hydrolysis 
(Gildberg and Almås, 1986). The market for the 
former product is the cosmetics industry; the latter 
is used as raw materials in the biochemical in­
dustry.
Enzymes from shrimp; alkaline 
phosphatase
When frozen blocks of shrimp are thawed in 
water before processing, enzymes are eluted. One 
of these enzymes is alkaline phosphatase. After 
removal of particles, the water is ultrafiltered and 
the alkaline phosphatase purified by an exchange 
chromatography (Olsen, Johansen and Myrnes, 
1990). This enzyme has properties that are impor­
tant in its use as a tool in diagnostic analysis. Sales 
have begun to producers of diagnostic kits.
The Use Of Enzymes In Fish Processing
The pepsins and other proteolytic enzymes 
(trypsins, chymotrypsins, peptidases) present in 
fish and other marine organisms differ significant­
ly from their counterparts in warm-blooded 
animals and offer distinct advantages for certain 
applications(Gildberg, 1982). For example, the 
fish pepsins have a higher pH optimum than other 
pepsins and they are active at low temperature and 
they are very resistant to autolysis at low pH. It has 
also been demonstrated that fish enzymes may 
have distinctly different pH optima when acting on 
different tissues. Lysozymes of scallops and blue 
mussels are active at acid pH and they retain 40% 
of maximal activity at 4°C. Moreover, these 
lysozymes are able to attack the cell wall of Grant- 
negative bacteria without the presence of chelators 
(Myrnes, 1991).
Fish tissues and the tissues of marine inver­
tebrates differ very much from corresponding 
tissues of warm-blooded animals with regard to 
sensitivity to various enzymes. This under­
standing of the mode of action of marine enzymes 
on various tissues, combined with knowledge of 
the sensitivity of various tissues of marine or­
ganisms to a long series of enzymes, also of plant 
and animal origin, formed the basis for a very 
specialized expertise in Troms0. Specifically, this 
relates to the use of enzymes as processing aids, 
and the abilities to biochemically dissect and 
separate biological tissues.
A number of such enzymatic processing 
methods have been further developed by the com­
pany KS Biotec-Mackzymal to a state of high 
sophistication. This company can now provide 
complete processing lines, designed according to 
the specifications given by the enzyme tech­
no log ists. Some of these p rocesses are 
summarised below.
Enzymatic caviar production
The eggs of fatty fishes are firmly attached to 
the connective tissues of the roe sacs. Even though 
mechanical processing of roe is feasible with 
several fish species this does not apply to many 
fatty fishes whose eggs are too fragile to survive 
the treatment. Mechanical caviar production of roe 
from such fishes normally involves rubbing the 
roe against a sieve or screen. This results in high 
damage and poor yield. Thus, there are a number 
of fish species from which the roe cannot be con­
verted into caviar, but in which the extent of roe 
maturation may also make processing impossible. 
The raw materials available for the production of 
high value caviar for the delicatessen market are 
therefore limited.
However, the eggs can be released from the 
connective tissues using enzymes that selectively 
degrade the connective tissues without damaging 
the eggs. The strength of individual eggs can also 
be adjusted at will to meet the requirements of 
various markets. KS Biotec-Mackzymal supplies 
the enzymes necessary for performing that process
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and the processing lines where such caviar is 
produced.
The main advantages of enzymatically 
produced caviar compared with that produced 
mechanically can be summarized as follows:
Better recovery (up to 92%, depending 
on species).
Less damage to the eggs (makes 
production of other roe types and a 
wider variety of maturity possible). 
Cleanliness of product with no residues 
of connective tissues.
Less drip loss during thawing if the 
resulting caviar is frozen.
Less labour is required for processing. 
Good hygiene in production.
KS Biotec-Mackzymal has demonstrated the 
viability of the technology with the following sal­
monid fishes:
Chum salmon (Oncorhynchus keta) 
Rainbow trout (Oncorhynchus mykiss, 
previously Salmo gairdneri)
Pink salmon (Oncorhynchus 
gorbuscha)
Atlantic salmon (Salmo salar)
Coho salmon (Oncorhynchus kisutch) 
Sockeye salmon (Oncorhynchus nerka)
The method can most likely also be used to 
produce caviar from flying fish (Hilsa spp.), ocean 
catfish (wolffish) (Anarhicaslupus), paddlefish, 
sturgeon, catfish, mullet, carps (eg, Cyprinus car­
pio), whitefish and bowfin.
Complete processing units are delivered for 
the production of caviar by the enzyme method, 
and outside Norway the technology is being 
licenced to customers in the Soviet Union, Finland, 
Denmark, Faroe Islands, United Kingdom, 
Australia, USA and Canada.
Enzymatic removal o f squid skins
Specific squid skin degrading enzymes have 
been found in the intestine of the squid itself, and
in various plants. However, preparations of such 
enzymes also contain proteases which degrade the 
muscle. For practical use it was therefore neces­
sary to make an enzyme preparation in which the 
protease activity was low. With such a preparation 
an industrial squid deskinning line which produces 
skinless tubes, wings and tentacles from various 
squid species could be established.
KS Biotec-Mackzymal in collaboration with 
the Danish company Carnitech, has developed a 
processing line for deskinning of squid. The 
method can be used on the following types and 
genera of squid:
Illex spp.
Flying squid
Todarodes spp.
Nototodarus spp.
Cuttlefish
The muscle and tentacles of many squid 
species are too tough to be accepted well on certain 
markets. By including more of the proteases in the 
same enzyme preparation used for deskinning, the 
product can be tenderised simultaneously. The 
enzymatic tenderising process also results in im­
proved taste of the product, in particular of the 
tentacles.
Some other enzyme processes
Some enzyme processing methods other than 
those described above have been shown to work in 
practice and to have clear economic advantages. 
But development work necessary for market intro­
duction has not yet been carried out. Examples of 
such processes are the use of enzymes to remove 
scales from fish, to remove or tenderise skin of 
herring and tuna. One process which has been 
developed, namely loosening of shrimp shells from 
the muscle, is now ready to be adopted in industrial 
peeling of shrimp (patent pending).
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The Use Of Enzymes In Fish Feeds
Studies of the digestive processes of fish sug­
gest certain applications of enzymes as digestive 
aids in feed for fish.
Feed pellets disintegrate quickly in the 
stomach of fish. The slurry which is formed passes 
on through the pylorus node after a relatively short 
time of exposure to the stomach pepsins. It is 
therefore assumed that a large proportion of protein 
particles rather than soluble peptides are 
transported to the gut when fish consume pelleted 
feeds. Natural preys are, in contrast, digested 
from the surface and inwards in a process which 
releases a soup of peptides. It is further assumed 
that protein particles in the gut may create an 
overloading of its digestive capacity. To compen­
sate for the short exposure time in the stomach, fish 
pepsins may be added to the fish feed as a digestive 
aid. The pepsins produced by Marine Biochemi­
cals A/S have been shown to enhance growth of 
fish, and the company manufactures and exports 
pepsins for this application.
Fish Vaccines, Adjuvants And 
Prophylactic Agents
Vaccines
Studies of the microbiology of marine vibrios 
that cause disease in fanned salmonids were made 
at the University of Tromsoe in 1973. Cold- 
adapted strains of Vibrio anguillarum were 
isolated from fanned fish in north Norway and it 
was shown that environmental contaminants 
reduce the resistance of fish to vibrioses (Egidius 
et al, 1982; Olafsen, Christie and Raa, 1981). A 
novel disease in Norwegian fish farms was dis­
covered in 1979. Researchers in Tromsoe and at 
the Marine Institute in Bergen were, in 1981, able 
to demonstrate that the disease was caused by a 
hitherto undescribed Vibrio species. The disease, 
which has been called "Hitra-disease", soon be­
came the most serious threat to the Norwegian 
salmon farming industry, causing losses, which, in 
1987 amounted to more than 200 million Nor­
wegian kroner (30 million US$).
The research community in Tromsoe had the 
necessary qualifications and experience to quickly 
develop a vaccine against this disease (Espelid, 
Hjelmeland and Jørgensen, 1987). After a 
thorough description of the biochemistry and 
growth characteristics of the disease causing or­
ganism, which researchers in Bergen designated 
Vibrio salmonicida, the time was ripe for pilot- 
scale production and efficacy-testing of a vaccine. 
This was produced on a commercial basis by 
Apothekernes Laboratorium A/S, a pharmaceutical 
company which diversified into this sector when it 
established the fish vaccine production plant in 
Tromsoe.
The vaccine against "Hitra-disease" is very 
efficient, causing a more than 90% protection 
against the disease. As a result, the use of an­
tibiotics in Norwegian fish farms dropped 
drastically and fish fanners have avoided potential 
losses in the range of 300-400 million Norwegian 
kroner a year. In other words the economic gain 
from this project is of an order of magnitude higher 
than the total costs of the research and development 
work which formed the basis for the vaccine.
F uruncu losis in salm on, caused by 
Aeromonas salmonicida, first became a serious 
problem for Norwegian fish farmers a few years 
ago. The bacterium quickly develops resistance to 
antibiotics and, moreover, has the ability to escape 
the action of the immune system of fish. Conven­
tional vaccines against this disease have therefore 
not been very effective.
Adjuvants/immunostimulants
Recently a new adjuvant and general im­
munostimulant has been developed in Tromsø and 
is now being produced commercially by the 
company KS Biotec-Mackzymal. The immunos­
timulant is a B-1.3/B-1.6-gIucan derived from 
yeast. Its trade name is MacroGard.
A series of experiments have demonstrated 
that MacroGard alone causes a substantial increase 
of resistance in fish to a number of different dis­
eases (Robertson et al, 1990). The compound is 
effective, both after injection and when ad­
ministered in the feed. When used as an adjuvant
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in a vaccine prepared from killed Aeromonas sal­
monicida, the degree of protection has been about 
90%. A furunculosis vaccine with MacroGard as 
adjuvant has recently come in commercial produc­
tion in Norway.
MacroGard induces increased resistance 
against many diseases simultaneously, by activat­
ing the macrophages. When animals are treated 
with glucans, their macrophages produce more in­
terleukin, a polypeptide which activates B- and 
T-lymphocytes. The lymphocytes then produce 
interferone-like molecules which activate the mac­
rophages so they become more active in engulfing 
and killing of bacteria. This in turn leads to a 
cascade of events which results in higher general 
resistance to infection by both bacteria and viruses.
Scientific Expertise In Tromsoe
Based on the activities in Tromsoe over the 
last 15 years a strong scientific network has been 
established. Applied fundamental research is car­
ried out as well as applied R & D within:
Enzyme biotechnology, purification, in­
dustrial production and application of 
enzymes.
Fish health; production of vaccines 
against bacterial fish diseases and ap­
plication of feed additives (eg, glucans) 
in preventive health treatment.
Fish immunology, research on defence 
mechanisms against fish diseases.
Fish nutrition; development of feed, eg, 
starter feed for marine larvae and fry, 
fermented feed and fish silage. 
Microbial ecology, studies of the in­
fluence of the environment on 
micro-organisms and fish health.
New Commercial Companies In Tromsoe
In the previous chapter we have given a brief 
description of some R & D results from projects 
carried out in Tromsoe. These projects have given 
results that have been and are being commercial­
ized. Initially, the researchers studied the
possibility of improving the utilization of fish raw 
material, eg, fish waste. Some of these options 
looked commercially promising and the companies 
involved are scaling up for production based on 
market opportunities and requirements.
Commercial Production And Companies 
In Tromsoe
In Tromsoe (and northern Norway generally) 
few companies have the financial resources, know­
how and production of products to take commercial 
advantage of these R & D results. In fact, very few 
companies in all of Norway are strategically and 
financially able to do so. In the mid-80’s the en­
vironm ent favoured the s ta rtin g  up new 
businesses, in high-technology production fields, 
including marine biotechnology and aquaculture. 
Contacts at personal and institutional levels 
resulted in the establishment of the companies in 
Tromsoe as shown in Table 1.
The products that these companies are 
producing and developing on commercial scale 
which have been presented in the earlier chapter, 
are summarized below:
1. KS Biotec-Mackzymal Enzymatic 
processing, 
adjuvants, others
2. Marine Biochemicals Biochemicals: 
pepsin, peptone, 
DNA, ALP
3. Apothekernes Lab. Vaccines
Additionally, the production of fish silage 
concentrate is carried out by Rieber & Co, Trom­
soe. This company has long been involved in small 
scale production of marine lipids. The combined 
production of lipids and silage concentrate is car­
ried out in a large scale operation (20,000 mt per 
year).
These Tromsoe companies represent a 
powerful base for expansion into viable commer­
cial operations. This opens the door to possible 
production of a wide range of products made from 
marine raw materials, for use in fish processing, in 
pharmaceuticals and in other items.
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Table 1. Marine biotechnology companies established in Tromsoe.
C o m p a n y Y e a r O w n e r s
A S  B i o t e c 1 9 8 4 -  P r o f e s s o r  J . R a a  a n d  
g r a d u a t e  s t u d e n t s
1 9 8 5 -  9 0 %  S e l m e r  S a n d e  B i o c o m p .  
( S A B I C O )
1 9 9 0 -  I n it ia l  o w n e r s  1 0 0 %
M a c k z y m a l 1 9 8 6 •  A S  B i o t e c  a n d  L .  M a c k s  
B r e w e r y ,  T r o m s o e
K S  B i o t e c - M a c k z y m a l 1 9 9 0 -  A S  B i o t e c ,  L .  M a c k s  
B r e w e r y  a n d  P r o v e s t a  
( P h i l l i p s  P e t r o le u m  C o m p a n y )
M a r in e  B i o c h e m i c a l s  A S 1 9 8 5 -  N o r s k  H y d r o  ( l a r g e s t  
N o r w e g ia n  C o m p a n y )
1 9 9 1 -  E m p l o y e e s :  T . S t r ø m  a n d  
J .  R a a
A p o t h e k e r n e s  L a b .  
P r o d u c t io n  u n it  in  
T r o m s o e  ( v a c c i n e )
1 9 8 6 -  A p o t h e k e r n e s  L a b .  A S
Factors For Success And Failure
Documentation/Markets
The overall aim in commercial applications 
is to meet market requirements. For new products, 
extensive documentation is required to convince 
potential buyers to make their first purchases. The 
new companies in Tromsoe have found that 
documentations compiled in collaboration with 
scientists from universities orR & D institutes have 
high credibility and build confidence in the new 
enterprises.
Production
Production of the vaccine developed in 
Tromsoe against salmon disease began after a 
heavy investment in a modern production plant. 
With close cooperation from government agencies 
in approving the vaccine and by strong marketing 
efforts, full scale production and sales quickly 
developed.
The other companies experienced a more 
traumatic development, resulting in financial dif­
ficulties after 2-5 years and final sale of the 
companies to new owners. These included the 
founders and key personnel of these companies. 
One reason for this outcome was lack of investment 
in production facilities; the financers required reli­
able cash flow analyses prior to investment, which 
the project leaders were not able to give. Without 
this investment, the companies could only "sell" 
potential production on the basis of laboratory- 
scale production. This slowed down the 
demonstration of commercial applications to ac­
tual customers.
Both KS Biotec-Mackzymal and Marine 
Biochemicals AS have now industrial production 
facilities for their products.
Time From R & D To Positive Results
New companies in Norway have generally 
found that the time required for developing R & D 
results into commercially viable production is 5-10 
years. This is a longer period than expected by
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researchers and economists in the mid-80’s. In 
addition, the general situation in aquaculture was 
not so promising in 1990, as it had been a few years 
previously. As a result, the economists who had 
supported foundation of two of the new companies 
lost faith in their investment possibilities. This 
resulted in sale of the companies to new owners.
Equity Capital
The new Tromsoe companies have made 
heavy investments in equipment, in the order of 
100 million NOK (15-20 million US $). Only 
companies with strong financial base are willing to 
invest in such high risk/long term projects, as the 
projects above admittedly are.
However, no industry can be developed 
without risk capital to finance the final prepara­
tions for pilot-scale and industrial productions. 
And more money is needed when the time comes 
to invest in production facilities, product control 
and market introduction.
Summary Of Our Experience
On the basis of 15 years’ experience in R & D 
and industrialization, we offer the following sum­
mary of requirements important to success:
1. Development based on natural ad­
vantages related to resources and 
industrial traditions
2. Network with academic R & D groups
3. Entrepreneurs with innovative strength, 
intuition and profound knowledge of 
the products and its applications
4. Investment in pilot plants and industrial 
production facilities prior to reliable 
cash-flow analysis
5. Government funding support
6. Long term investors (5-10 years)
7. Personal involvement in the companies 
of key employees.
In addition, our work in Tromsoe since 1975 
indicates that there are very few short cuts to suc­
cess. Success requires hard work at every stage,
from research to commercial-scale production and 
marketing.
C l a u s e n ,  E . ,  G i ld b e r g ,  A .  a n d  R a a ,  J . 1 9 8 5 .  P r e p a r a t io n  
a n d  t e s t i n g  o f  a n  a u t o l y s a t e  o f  f i s h  v i s c e r a  a s  
g r o w t h  s u b s t r a t e  f o r  b a c t e r i a .  A p p l . E n v .  
M i c r o b i o l o .  5 0 : 1 5 5 6 - 1 5 5 7 .
E g i d i u s ,  E . ,  A n d e r s e n ,  K . ,  C l a u s e n ,  E . a n d  R a a ,  J . 1 9 8 2 .  
B a t h - v a c c in a t io n  a g a i n s t  v i b r i o s i s .  D e v e l o p m e n ­
ta l a n d  C o m p a r a t iv e  I m m u n o l o g y  2 : 1 9 3 - 1 9 6 .
E s p e l i d ,  S . ,  H j e l m e l a n d ,  K . a n d  J ø r g e n s e n ,  T .  1 9 8 7 .  T h e  
s p e c i f i c i t y  o f  A t l a n t i c  s a l m o n  a n t i b o d i e s  m a d e  
a g a in s t  t h e  f i s h  a t h o g e n  V i b r i o s a l m o n i c i d a ,  e s t a b -  
l i s h i n g  t h e  s u r f a c e  p r o t e i n  V S - P 1  a s  t h e  
d o m i n a t i n g  a n t i g e n .  D e v .  C o m p .  I m m u n o l . ,  
1 1 : 5 2 9 - 5 3 7 .
G i l d b e r g ,  A .  1 9 8 2 .  A u t o l y s i s  o f  f i s h  t i s s u e .  T h e s i s ,  
U n iv e r s i t y  o f  T r o m s o e .
G i ld b e r g ,  A .  a n d  A l m å s ,  K .A .  1 9 8 6 .  U t i l i z a t i o n  o f  f i s h  
v i s c e r a .  I n  F o o d  E n g i n e e r i n g  a n d  P r o c e s s  A p p l i c a ­
t i o n s ,  V o l .  2 ,  U n i t  O p e r a t i o n s  ( E d i t e d  b y  L e  
M a g u e r  M . a n d  J e l e n  P . )  p . 3 8 3 - 3 9 3 .  E l s e v i e r  
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D r  S tr ø m  i n f o r m e d  t h e  m e e t i n g  th a t  th e  e n z y m e s  
u s e d  in  t h e  p r o d u c t io n  o f  h i g h - q u a l i t y  c a v ia r  a r e  c o m ­
m e r c ia l l y  a v a i l a b l e  a n d  a r e  d i s t r ib u te d  b y  a N o r w e g ia n  
c o m p a n y .
B e c a u s e  v e r y  f e w  p e p t o n e s  a r e  p r o d u c e d  w o r l d ­
w i d e ,  d o c u m e n t a t i o n  o n  p e p t o n e s  i s  r e q u ir e d .
